(Precision Vaccinations) – The non-profit Institute for Molecular Medicine (IMM) confirmed on October 18, 2021, it has licensed its universal vaccine platform technology — called MultiTEP — to Nuravax, a biotech developing therapies for Alzheimer’s disease and other disorders of the central nervous system. MultiTEP is a vaccine platform that can generate very high levels of antibodies against […]

If you are alive today, you most likely know, or have known, someone afflicted with Alzheimer’s disease (AD). The World Health Organization estimates that more than 55 million people have dementia worldwide, with AD accounting for 60 to 70% of all cases. For decades, scientists have tested different hypotheses to find and fix the origins of the disease. Many […]

How can clinical trials be designed to best study therapies for treating long COVID? As progress is made in addressing the COVID-19 pandemic with vaccines and treatment pathways, reports about the long-term effects of the infection are building. Post-acute Sequelae of SARS-CoV-2 (PASC) (i.e., long COVID, long-term COVID, long-haul COVID) is an umbrella term used […]